Abstract 13973: Impaired Right Ventricular Hemodynamics Suggest Preclinical Pulmonary Hypertension in Patients With Metabolic Syndrome
Deepa M. Gopal(Boston University), Jennifer E. Ho(Massachusetts General Hospital), Courtney Donohue(Brigham and Women's Hospital), Rajalakshmi Santhanakrishnan(Cardiovascular Research Center), Wilson S. Colucci(Boston University), Nir Ayalon(Boston University), Youssef Rahban(University of Massachusetts Chan Medical School), Jill Downing(Boston University), Yi‐Chih Wang(Brigham and Women's Hospital), Noyan Gokce(Boston University), Alejandro J. Perez(Brigham and Women's Hospital), Chang‐seng Liang(Neusoft (China))
Cited by 0
Related Papers
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
|Circulation|2004|1.2k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
|Circulation|2023|1.1k
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
|New England Journal of Medicine|2000|908
Mitochondrial function as a therapeutic target in heart failure
|Nature Reviews Cardiology|2016|786